US 8852626
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
granted A61KA61K31/00A61K31/167
Quick answer
US patent 8852626 (Controlled-release CNS modulating compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/00, A61K31/167, A61K31/195, A61K31/197